
Glidivas MV 1mg/500mg/0.2mg Tablet
Marketer
Redmax Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glidivas MV 1mg/500mg/0.2mg Tablet
DiabetaComb 1mg/500mg/0.2mg tablets are classified as antidiabetic medications. This combined-therapy drug treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb 1mg/500mg/0.2mg tablets should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your doctor.
Uses of Glidivas MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glidivas MV 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glidivas MV 1mg/500mg/0.2mg Tablet whole; do not break, crush, or chew it. Administer this medication on an empty stomach.
Common Side effects of Glidivas MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glidivas MV 1mg/500mg/0.2mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glidivas MV 1mg/500mg/0.2mg Tablet whole; do not crush, chew, or divide it. Administer this medication on an empty stomach.
How Glidivas MV 1mg/500mg/0.2mg Tablet works:
A single Glidivas MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glidivas MV 1mg/500mg/0.2mg tablets with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Glidivas MV 1mg/500mg/0.2mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glidivas MV 1mg/500mg/0.2mg tablets while breastfeeding is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glidivas MV 1mg/500mg/0.2mg tablets is inadvisable for individuals with kidney impairment and should be strictly avoided. Patients with severe kidney disease are especially cautioned against its use; medical consultation is essential.
LiverCAUTION
Patients with liver impairment should use Glidivas MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate liver disease, initiate treatment with a low dose; however, its use is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glidivas MV 1mg/500mg/0.2mg Tablet :
Should you forget to take your Glidivas MV 1mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glidivas MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
